In line with this, genetic analyses of the PDO lines used for this study revealed typical mutational patterns and copy-number variations of CRC, such as alterations within the WNT, RAS, TP53, and TGFβ signaling pathways [41,46]. This evidence concerns the gene TP53 and colorectal carcinoma.